Literature DB >> 13714578

Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.

J G HIRSCH, A B CHURCH.   

Abstract

Studies have been made on phagocytosis and killing of Group A streptococci during mixing with suspensions of leucocytes in vitro. Under appropriate test conditions an anti-phagocytic effect can be demonstrated for the streptococcal hyaluronic acid capsule as well as for its M protein. The results obtained suggest an explanation for the suitability of human, but not rabbit, blood for opsonophagocytic tests designed to measure type-specific streptococcal antibodies. Human sera contain a factor which counteracts the anti-phagocytic effects of streptococcal hyaluronic acid capsules, and hence human blood serves well for detection of antibodies which combine with the only other phagocytosis-resisting component of this microorganism, namely M protein. In contrast, rabbit sera contain none of this factor, and addition of antibody to M protein to phagocytic test systems employing rabbit serum does not necessarily render the streptococci susceptible to engulfment by white cells, since the hyaluronic acid capsule may continue to interfere with phagocytosis. The nature of the human serum factor which opsonizes encapsulated streptococci is unknown. It does not appear to be an antibody or an enzyme capable of depolymerizing hyaluronic acid.

Entities:  

Keywords:  PHAGOCYTOSIS; STREPTOCOCCUS

Mesh:

Substances:

Year:  1960        PMID: 13714578      PMCID: PMC2137261          DOI: 10.1084/jem.111.3.309

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  The relationship of M protein and resistance to phagocytosis in the beta hemolytic streptococci.

Authors:  M MORRIS; C V SEASTONE
Journal:  J Bacteriol       Date:  1955-02       Impact factor: 3.490

2.  Mouse protection and enhancement of phagocytosis by antisera to Streptococcus pyogenes.

Authors:  D G FLECK
Journal:  Br J Exp Pathol       Date:  1956-08

3.  THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS.

Authors:  A G Kuttner; T F Lenert
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

4.  THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  E H Kass; C V Seastone
Journal:  J Exp Med       Date:  1944-03-01       Impact factor: 14.307

5.  Fate of non-virulent group A streptococci phagocytized by human and mouse neutrophils.

Authors:  A T WILSON; G G WILEY; P BRUNO
Journal:  J Exp Med       Date:  1957-12-01       Impact factor: 14.307

6.  Phagocytin: a bactericidal substance from polymorphonuclear leucocytes.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

7.  Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.

Authors:  G H STOLLERMAN; F S KANTOR; B D GORDON
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

8.  Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel.

Authors:  M J FOLEY; W B WOOD
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307

9.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : II. COMPARATIVE BACTERIOSTATIC EFFECT OF NORMAL WHOLE BLOOD FROM DIFFERENT ANIMAL SPECIES IN THE PRESENCE OF HUMAN CONVALESCENT SERA.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

10.  Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice.

Authors:  S ROTHBARD
Journal:  J Exp Med       Date:  1948-09-01       Impact factor: 14.307

  10 in total
  46 in total

1.  SELECTION OF GROUP A STREPTOCOCCI RICH IN M-PROTEIN FROM POPULATIONS POOR IN M-PROTEIN.

Authors:  C G BECKER
Journal:  Am J Pathol       Date:  1964-01       Impact factor: 4.307

Review 2.  BASIS FOR IMMUNITY TO TYPHOID IN MICE AND THE QUESTION OF "CELLULAR IMMUNITY".

Authors:  C R JENKIN; D ROWLEY
Journal:  Bacteriol Rev       Date:  1963-12

3.  Isozymes of lactic dehydrogenase in human tissues.

Authors:  E S VESELL; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

4.  The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system.

Authors:  C R JENKIN; D ROWLEY
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

5.  Adrenal steroids and infection: the effect of cortisone administration on polymorphonuclear leukocytic functions and on serum opsonins and bactericidins.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

6.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. III. Studies related to the vasoproliferative capability of polymorphonuclear leukocytes and lymphocytes.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1976-01       Impact factor: 4.307

7.  A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis.

Authors:  G A Higgs; E McCall; L J Youlten
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

8.  Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.

Authors:  J E Repine; C C Clawson; P S Friend
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.